ARWR — Arrowhead Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Arrowhead Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	315	368	376	396	677
Net Total Accounts Receivable
Net Total Receivables	0.846	10.3	1.41	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	322	385	405	420	695
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	47	66	169	336	431
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	523	710	692	766	1,140
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	40.7	147	139	105	103
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	60.7	301	293	494	954
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	462	409	399	271	185
Total Liabilities & Shareholders' Equity	523	710	692	766	1,140
Total Common Shares Outstanding